Bristol-Myers Squibb Co (NYSE:BMY)

66.85
BATS BZX Real-Time Price
As of 10:16am ET
 +0.13 / +0.19%
Today’s Change
42.48
Today|||52-Week Range
67.21
+4.14%
Year-to-Date
3 Attractive Dividend Stocks Whose Dividends Could Double
Jan 19 / MotleyFool.com - Paid Partner Content
All the 2020 Pre-JPM News Healthcare Investors Need to Know
Jan 11 / MotleyFool.com - Paid Partner Content
FDA Advisory Committee Slams Nektar's New Opioid Drug
Jan 15 / MotleyFool.com - Paid Partner Content
Here's Why Nektar Therapeutics Shares Rose as Much as 19.7% Today
Jan 10 / MotleyFool.com - Paid Partner Content
Why Nektar Therapeutics Stock Is Sinking Today
Jan 15 / MotleyFool.com - Paid Partner Content
Bristol-Myers Squibb's Celgene Unit Backs Out of a $55 Million Settlement
Jan 09 / MotleyFool.com - Paid Partner Content
2020 J.P. Morgan Healthcare Conference Roundup
Jan 13 / MotleyFool.com - Paid Partner Content
The Risk of Cancer-Related Death Is Dropping Faster Than Ever
Jan 08 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close66.72
Today’s open66.70
Day’s range66.54 - 67.19
Volume1,959,872
Average volume (3 months)15,969,653
Market cap$156.4B
Data as of 10:16am ET, 01/21/2020

Growth & Valuation

Earnings growth (last year)+392.14%
Earnings growth (this year)+10.18%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+8.59%
P/E ratio19.4
Price/Sales3.77
Price/Book7.72

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.40-0.78%
LLYEli Lilly and Co+0.48+0.34%
ABBVAbbVie+0.02+0.02%
SNYSanofi-0.44-0.86%
Data as of 10:16am ET, 01/21/2020

Financials

Next reporting dateJanuary 27, 2020
EPS forecast (this quarter)$0.89
Annual revenue (last year)$22.6B
Annual profit (last year)$4.9B
Net profit margin21.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts